Manuel Romero-Gómez-rekin lankidetzan egindako argitalpenak (2)

2024

  1. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 4, pp. 149-151

2020

  1. Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: How to manage in clinical practice

    Polish Archives of Internal Medicine, Vol. 130, Núm. 11, pp. 975-985